Finance

Lists
TEAM:NASDAQ
Atlassian Corp
$151.37
-0.60%
(-0.92) 1D
Nov 13, 10:39:26 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TEAM...
Open
$154.24
High
$155.63
Low
$150.85
Mkt. cap
38.21B
Avg. vol.
3.01M
Volume
393.78K
P/E ratio
416.08
52-wk high
$229.96
52-wk low
$56.01
EPS
$0.36
Beta
1.16
Shares outstanding
157.72M
No. of employees
13K
Open
$154.24
High
$155.63
Low
$150.85
Mkt. cap
38.21B
Avg. vol.
3.01M
Volume
393.78K
P/E ratio
416.08
52-wk high
$229.96
52-wk low
$56.01
EPS
$0.36
Beta
1.16
Shares outstanding
157.72M
No. of employees
13K
News stories
From web sources and news partners
Profile
Atlassian is a multinational proprietary software company headquartered in Sydney, Australia, that specialises in collaboration tools designed primarily for software development and project management. Founded in Sydney in 2002, the company has over 12,000 employees across 14 countries. Atlassian currently serves over 300,000 customers in over 200 countries and territories around the world. Atlassian maintains its global headquarters in Sydney, alongside a secondary US hub in San Francisco. In 2013, the group established UK-registered Atlassian Corporation Plc as its parent entity. In 2022, the group completed a corporate reorganisation, establishing a US-domiciled parent holding company, Atlassian Corporation - incorporated in Delaware, to replace the UK entity. Wikipedia
About Atlassian Corp
CEOMike Cannon-Brookes
Employees13.3K
Founded2002
Headquarters-
SectorInformation Technology
IndustryApplication software
Analyst ratings
Based on 20 analysts giving stock ratings to TEAM in the past 3 months
Strong buy
Buy
19
Hold
1
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for TEAM in the last 3 months.
Highest
Current $151.37
$309.00 (+104.14%)
Average
$221.05 (+46.03%)
Lowest
$175.00 (+15.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Fatima Boolani
Citi
Buy
Maintained
$220.00
+45.3%
11/09/2026
Raimo Lenschow
Barclays
Buy
Maintained
$210.00
+38.7%
11/09/2026
David Hynes
Canaccord Genuity
Buy
Maintained
$175.00
+15.6%
11/05/2026
Ittai Kidron
Oppenheimer
Buy
Maintained
$240.00
+58.6%
11/06/2026
Thomas Blakey
Cantor Fitzgerald
Buy
Reiterated
$252.00
+66.5%
11/06/2026
Keith Bachman
BMO Capital
Buy
Maintained
$200.00
+32.1%
11/06/2026
Matthew Hedberg
RBC Capital
Buy
Maintained
$235.00
+55.2%
11/05/2026
Howard Ma
Guggenheim
Buy
Maintained
$280.00
+85%
11/05/2026
Adam Wood
Morgan Stanley
Buy
Maintained
$180.00
+18.9%
11/06/2026
Miller Jump
Truist Financial
Buy
Reiterated
$200.00
+32.1%
11/06/2026
Ryan MacWilliams
Wells Fargo
Buy
Reiterated
$200.00
+32.1%
11/06/2026
Allan Verkhovski
BTIG
Buy
Maintained
$240.00
+58.6%
11/06/2026
Robert Oliver
Robert W. Baird
Buy
Maintained
$225.00
+48.6%
11/06/2026
Rob Owens
Piper Sandler
Buy
Reiterated
$190.00
+25.5%
11/06/2026
Koji Ikeda
Bank of America Securities
Buy
Reiterated
$225.00
+48.6%
11/06/2026
Brent Thill
Jefferies
Buy
Maintained
$190.00
+25.5%
11/06/2026
Jason Celino
KeyBanc
Buy
Maintained
$235.00
+55.2%
11/06/2026
Derrick Wood
TD Cowen
Hold
Maintained
$180.00
+18.9%
11/03/2026
Gregg Moskowitz
Mizuho Securities
Buy
Maintained
$235.00
+55.2%
10/15/2026
Peter Weed
Bernstein
Buy
Maintained
$309.00
+104.1%
08/28/2026
Adam Tindle
Raymond James
Buy
Maintained
$180.00
+18.9%
08/07/2026
Karl Keirstead
UBS
Hold
Reiterated
$160.00
+5.7%
08/07/2026
Unknown Analyst
Bank of China
Buy
Upgraded
$175.00
+15.6%
08/07/2026
Arjun Bhatia
William Blair
Buy
Reiterated
-
-
08/07/2026
Andrew Sherman
TD Cowen
Hold
Maintained
$105.00
-30.6%
07/16/2026
Keith Weiss
Morgan Stanley
Buy
Maintained
$120.00
-20.7%
05/07/2026
Unknown Analyst
Macquarie
Buy
Maintained
$130.00
-14.1%
05/01/2026
Last report
Nov 6, 2026
Fiscal period
Q1 2027
$1.65 / $1.43
+15.73%beat
Revenue / Est. (USD)
1.77B / 1.71B
+3.40%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.59B
1.79B
1.77B
1.77B
Cost of goods sold
237.69M
241.73M
237.81M
261.92M
Cost of revenue
237.69M
241.73M
237.81M
261.92M
Research and development expenses
826.49M
798.43M
755.95M
758.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
569.88M
579.26M
556.13M
562.56M
Operating expense
1.40B
1.38B
1.31B
1.32B
Total operating expenses
1.63B
1.62B
1.55B
1.58B
Operating income
-47.75M
167.55M
216.58M
188.79M
Other non operating income
-13.55M
-4.92M
-6.20M
-9.56M
EBT including unusual items
-55.76M
-62.79M
196.92M
170.20M
EBT excluding unusual items
-55.76M
161.04M
205.49M
177.12M
Income tax expense
-13.11M
35.60M
57.85M
79.47M
Effective tax rate
23.52%
-56.69%
29.38%
46.70%
Other operating expenses
-
-
-
-
Net income
-42.64M
-98.39M
139.08M
90.72M
Net profit margin
-2.69%
-5.51%
7.87%
5.12%
Earnings per share
1.22
1.75
1.87
1.65
Interest and investment income
18.06M
12.55M
9.25M
12.08M
Interest expense
-12.52M
-14.14M
-14.15M
-14.20M
Net interest expenses
5.54M
-1.59M
-4.90M
-2.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.13M
208.83M
256.01M
228.45M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps